Brief: Abbisko Cayman Posts H1 Revenue RMB 657.1 Million
04/08/2025 18:10
Aug 4 (Reuters) - Abbisko Cayman Ltd 2256.HK: H1 REVENUE RMB 657.1 MILLION H1 NET INCOME RMB 328.5 MILLION Further company coverage: 2256.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Abbisko Cayman
See all newsHK-listed Abbisko climbs most in 12 weeks on Eli Lilly tie-up
Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly (updated)
Brief: Abbisko Therapeutics Deepens R+D- Collaboration With Lilly
Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly
Brief: Abbisko Therapeutics Enters Strategic Research Collaboration And License Agreement With Eli Lilly